Clin2
NCT07302035Likely a fitNot yet recruiting

Safety study of a single vaginal dose in healthy women

Bacterial Vaginosis

Part of Infections, Women’s health & pregnancy clinical trials.

This trial tests a single dose of an investigational drug given vaginally to healthy Chinese women. It aims to see if the drug is safe and how the body processes it.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are a healthy woman of childbearing age (18 to 55 years old).
  • You are sexually active and agree to use only the study product vaginally, avoiding other vaginal products like creams, sponges, or lubricants.
  • Your medical history, vital signs, physical exam, gynecological exam, lab tests, and ECG show no significant abnormalities, or any mild issues are deemed not important by the doctor.
  • You have not had stinging, burning, bleeding, itching, redness, swelling, or unusual discharge from past or current vaginal products, and you have no genital malformations or other factors that could affect vaginal use.
  • You have not had a serious infection, chronic infection, or infection needing antibiotics within 4 weeks before the study, and no major vaginal, pelvic, or cervical surgery within 90 days, and no hysterectomy ever.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06450990Not yet recruiting· Phase 1/Phase 2
Testing a probiotic for vaginal infections

This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.

NCT07663838Not yet recruiting· Phase 1
New vaginal gel for bacterial vaginosis

This study tests a new vaginal gel for bacterial vaginosis (BV) in women aged 18-50. It aims to see if the gel is safe and works better than current treatments.

Beijing, Beijing Municipality
NCT07483671Not yet recruiting· Phase 2
Study of BPR-101 capsules with metronidazole for bacterial vaginosis

This trial tests a combination of BPR-101 capsules (a probiotic) and an antibiotic (metronidazole) for women with bacterial vaginosis (BV). The goal is to see if this combination is more effective and safe than standard treatment alone.

Tianjin
NCT07703241Not yet recruiting
Vaginal ovule for bacterial vaginosis and yeast infection

This trial tests a vaginal ovule (a small insert) medical device to treat bacterial vaginosis and yeast infections. It aims to see if the device is safe and effective at relieving symptoms like discharge, itching, and burning.

Naples
NCT06458543Recruiting· Phase 4
Study on better treatment for bacterial vaginosis

This trial compares different ways to treat bacterial vaginosis (a common vaginal infection) in women who are not pregnant and are between 18 and 45 years old. The goal is to find which treatment works best and is easiest to follow.

Korolyov
NCT06472765Enrolling by invitation
Study of the Vaginal Ecosystem in Healthy Women

This study looks at the natural balance of bacteria and other factors in the vagina of healthy women. It aims to learn more about what a healthy vaginal ecosystem looks like.

Fullerton, California

Hear when a new Bacterial Vaginosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.